✨ Free AI Report
Evoke Pharma Inc: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Evoke Pharma Inc
Company Research

Evoke Pharma Inc: Business Overview, Financials & Competitive Analysis

Evoke Pharma Inc, founded in 2007, is a specialty pharmaceutical company focused on the development and commercialization of treatments for gastrointestinal (GI) diseases. Headquartered in Solana...

Analyst-debate audio for Evoke Pharma Inc

AskCyborg analysts argue the bull and bear cases for Evoke Pharma Inc across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Company Overview of Evoke Pharma IncProduct Portfolio of Evoke Pharma IncLeadership and Management Team of Evoke Pharma IncFinancial Overview of Evoke Pharma IncMarketing Strategies of Evoke Pharma IncMarket Overview and Competitors of Evoke Pharma Inc
Get Interactive Report Freeor start reading below
Live on AskCyborg
5/10Mixed
Evoke Pharma, Inc.

Specialty pharma with compelling monopoly position in diabetic gastroparesis but insufficient scale to achieve profitability independently.

▶︎ Listen to the 90-second analyst debate
5/ 10Mixed

Cyborg Score thesis

Specialty pharma with compelling monopoly position in diabetic gastroparesis but insufficient scale to achieve profitability...

Read the full analyst-debate transcript →
Industry Specialty Pharmaceuticals / Gastrointestinal Therapeutics
2 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: August 17, 2026
AI-Verified Research
30+ Page Report

Get the Latest Evoke Pharma Inc Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Evoke Pharma Inc, founded in 2007, is a specialty pharmaceutical company focused on the development and commercialization of treatments for gastrointestinal (GI) diseases. Headquartered in Solana Beach, California, the company’s mission is to improve the lives of patients suffering from GI conditions through innovative drug therapies.

Company Overview of Evoke Pharma Inc

Pro stress-test →

Evoke Pharma Inc specializes in addressing unmet medical needs in the field of gastroenterology. The company leverages its deep expertise in pharmacology, regulatory affairs, and clinical development to bring innovative therapies to market. The primary focus of Evoke Pharma Inc is on developing products that can significantly enhance patient outcomes in the GI space.

Product Portfolio of Evoke Pharma Inc

Pro stress-test →

Evoke Pharma Inc’s flagship product is Gimoti, a nasal spray formulation of metoclopramide for the relief of symptoms associated with acute and recurrent diabetic gastroparesis. Gimoti is designed to offer a non-oral route of administration, providing an alternative for patients who have difficulty with oral medications. This innovative delivery system addresses the challenges faced by many gastroparesis patients, offering a more effective and convenient treatment option.

Leadership and Management Team of Evoke Pharma Inc

Pro stress-test →

The leadership team at Evoke Pharma Inc is comprised of seasoned professionals with extensive experience in the pharmaceutical and biotechnology industries. Key members include:

  • David A. Gonyer, R.Ph. – President and CEO: With over 30 years of experience, Mr. Gonyer has a strong background in pharmaceutical sales, marketing, and business development.
  • Matthew D. D’Onofrio – Executive Vice President and COO: Mr. D’Onofrio brings over 25 years of experience in the pharmaceutical industry, with expertise in operations, regulatory affairs, and commercial strategy.
  • Martha J. Demski – Chief Financial Officer: Ms. Demski has over 30 years of financial and operational experience in the life sciences sector.

Financial Overview of Evoke Pharma Inc

Evoke Pharma Inc’s financial status reflects its strategic investments in product development and commercialization. The company has successfully raised capital through public offerings and maintains a strong focus on fiscal responsibility. Key financial metrics include revenue growth from Gimoti sales and prudent management of operating expenses.

Marketing Strategies of Evoke Pharma Inc

Evoke Pharma Inc employs a multi-faceted marketing approach to promote its products. The company leverages digital marketing, targeted advertising, and partnerships with healthcare providers to increase awareness and adoption of Gimoti. Additionally, Evoke Pharma Inc engages in educational initiatives to inform both patients and healthcare professionals about the benefits of its therapies.

Market Overview and Competitors of Evoke Pharma Inc

The gastroenterology market is highly competitive, with numerous companies vying for market share. Key competitors include larger pharmaceutical companies with extensive resources and established product lines. However, Evoke Pharma Inc differentiates itself through its focus on innovative delivery systems and addressing unmet medical needs in niche markets.

Sales Strategies of Evoke Pharma Inc

Evoke Pharma Inc utilizes a direct sales force to reach healthcare providers and pharmacies. The company also partners with specialty pharmacies to ensure that patients have access to Gimoti. Additionally, Evoke Pharma Inc employs a robust patient support program to assist with access and adherence to therapy.

Technologies Utilized by Evoke Pharma Inc

Evoke Pharma Inc leverages advanced drug delivery technologies to enhance the efficacy and convenience of its therapies. The development of Gimoti’s nasal spray formulation is a testament to the company’s commitment to innovation and improving patient outcomes.

HR Practices at Evoke Pharma Inc

Evoke Pharma Inc places a strong emphasis on its human resources practices, fostering a collaborative and inclusive work environment. The company offers competitive benefits, professional development opportunities, and a culture that values diversity and teamwork. These practices help attract and retain top talent in the industry.

Corporate Responsibility of Evoke Pharma Inc

Evoke Pharma Inc is committed to corporate social responsibility (CSR) initiatives, focusing on sustainability, ethical business practices, and community engagement. The company actively participates in charitable activities and supports organizations dedicated to improving public health and well-being.

Future Plans of Evoke Pharma Inc

Looking ahead, Evoke Pharma Inc aims to expand its product portfolio and explore new therapeutic areas within gastroenterology. The company is dedicated to advancing its research and development efforts, seeking to bring additional innovative treatments to market. Strategic partnerships and collaborations will also play a key role in driving future growth and success.


Discover detailed insights and analysis about Evoke Pharma Inc by subscribing to our comprehensive report.

What the analysts stress-tested

The top findings that survived the multi-agent debate for Evoke Pharma Inc.

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Evoke Pharma Inc has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Metoclopramide (oral formulations)Generic oral gastroparesis treatmentDomperidoneAlternative dopamine antagonist for gastroparesis

Compare Evoke Pharma Inc with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Evoke Pharma Inc operates in Specialty Pharmaceuticals / Gastrointestinal Therapeutics. See how the rest of the sector scores on the Cyborg framework.

Browse Specialty Pharmaceuticals / Gastrointestinal Therapeutics research →
NEW · MCP server

Ask your AI assistant about Evoke Pharma Inc

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Evoke Pharma Inc and its top competitor on Cyborg Score”
“What did Evoke Pharma Inc do this quarter?”
“Is Evoke Pharma Inc a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Evoke Pharma Inc do?+
Evoke Pharma Inc, founded in 2007, is a specialty pharmaceutical company focused on the development and commercialization of treatments for gastrointestinal (GI) diseases. Headquartered in Solana...
What is Evoke Pharma Inc's Cyborg Score?+
Evoke Pharma Inc has a Cyborg Score of 5/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Evoke Pharma Inc's main competitors?+
Named competitors include Metoclopramide (oral formulations), Domperidone. The full competitive landscape is in the AskCyborg report.
How can I get the full Evoke Pharma Inc research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Evoke Pharma Inc research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Evoke Pharma Inc over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Company Research

Gambling and Lotteries Industry BriefingStationery and Office Products Industry BriefingDefense Tech Industry BriefingAi Infrastructure Systems Industry BriefingPet Insurance Industry BriefingSelf-Storage Industry BriefingMetal Additive Manufacturing Industry BriefingAi Accelerator Hardware Systems Industry BriefingLuxury Wines & Spirits Industry BriefingEnzymatic Plastic Recycling Industry BriefingInfrastructure as a Service (IaaS) Industry Briefingluxury fashion apparel Industry Briefing

Explore Industry Research

Travel Insurance Industry Company Research ReportSecurity Services Industry Company Research ReportLandscaping and Grounds Maintenance Industry Company Research ReportJanitorial and Cleaning Services Industry Company Research ReportSustainability Consulting Industry Company Research ReportReal Estate Investment Trusts (REITs) Industry Company Research Report
Browse All Company ResearchBrowse All Industry ResearchRSS Feed